Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The report details the trend, potential and market size of Anti-infective Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-infective Drugmarket, defines the market attractiveness level of Anti-infective Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-infective Drug industry, describes the types of Anti-infective Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-infective Drug market and the development prospects and opportunities of Anti-infective Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-infective Drug market in Chapter 13.
By Player:
Johnson & Johnson
Gilead Sciences
Merck & Co
Teva Pharmaceutical Industries Ltd
Pfizer
Bristol-Myers Squibb
Novartis
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
F Hoffmann-La Roche Ltd
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Drugs Store
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-infective Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-infective Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-infective Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-infective Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-infective Drug Market Analysis and Outlook to 2022
-
7.1 Global Anti-infective Drug Consumption (2017-2022)
-
7.2 United States Anti-infective Drug Consumption (2017-2022)
-
7.3 Europe Anti-infective Drug Consumption (2017-2022)
-
7.4 China Anti-infective Drug Consumption (2017-2022)
-
7.5 Japan Anti-infective Drug Consumption (2017-2022)
-
7.6 India Anti-infective Drug Consumption (2017-2022)
-
7.7 South Korea Anti-infective Drug Consumption (2017-2022)
8 Region and Country-wise Anti-infective Drug Market Analysis and Outlook to 2028
-
8.1 Global Anti-infective Drug Consumption Forecast (2022-2028)
-
8.2 United States Anti-infective Drug Consumption Forecast (2022-2028)
-
8.3 Europe Anti-infective Drug Consumption Forecast (2022-2028)
-
8.4 China Anti-infective Drug Consumption Forecast (2022-2028)
-
8.5 Japan Anti-infective Drug Consumption Forecast (2022-2028)
-
8.6 India Anti-infective Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-infective Drug Consumption Forecast (2022-2028)
9 Global Anti-infective Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-infective Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-infective Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-infective Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-infective Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-infective Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-infective Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-infective Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-infective Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-infective Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-infective Drug Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Anti-infective Drug Product and Service
-
14.2 Gilead Sciences
-
14.2.1 Gilead Sciences Company Details
-
14.2.2 Gilead Sciences Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gilead Sciences Anti-infective Drug Product and Service
-
14.3 Merck & Co
-
14.3.1 Merck & Co Company Details
-
14.3.2 Merck & Co Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co Anti-infective Drug Product and Service
-
14.4 Teva Pharmaceutical Industries Ltd
-
14.4.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.4.2 Teva Pharmaceutical Industries Ltd Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceutical Industries Ltd Anti-infective Drug Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Anti-infective Drug Product and Service
-
14.6 Bristol-Myers Squibb
-
14.6.1 Bristol-Myers Squibb Company Details
-
14.6.2 Bristol-Myers Squibb Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Anti-infective Drug Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Anti-infective Drug Product and Service
-
14.8 GlaxoSmithKline plc
-
14.8.1 GlaxoSmithKline plc Company Details
-
14.8.2 GlaxoSmithKline plc Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline plc Anti-infective Drug Product and Service
-
14.9 Boehringer Ingelheim GmbH
-
14.9.1 Boehringer Ingelheim GmbH Company Details
-
14.9.2 Boehringer Ingelheim GmbH Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim GmbH Anti-infective Drug Product and Service
-
14.10 F Hoffmann-La Roche Ltd
-
14.10.1 F Hoffmann-La Roche Ltd Company Details
-
14.10.2 F Hoffmann-La Roche Ltd Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 F Hoffmann-La Roche Ltd Anti-infective Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-infective Drug
-
Figure Anti-infective Drug Picture
-
Table Global Anti-infective Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-infective Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-infective Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-infective Drug Consumption by Country (2017-2022)
-
Figure United States Anti-infective Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-infective Drug Consumption and Growth Rate (2017-2022)
-
Figure China Anti-infective Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-infective Drug Consumption and Growth Rate (2017-2022)
-
Figure India Anti-infective Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-infective Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-infective Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-infective Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-infective Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-infective Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-infective Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-infective Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-infective Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-infective Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-infective Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Anti-infective Drug Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Anti-infective Drug Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Anti-infective Drug Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Anti-infective Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-infective Drug Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Anti-infective Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anti-infective Drug Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Anti-infective Drug Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Anti-infective Drug Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Anti-infective Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Anti-infective Drug Product and Service
-
